CARE Ratings Ltd Q2 FY27 results are out (Jul–Sep 2026) →Revenue ₹164 Cr +20.6% YoYSee revenue, profit and what management said. You are viewing Q1 FY26.
CR

CARE Ratings Ltd

Q1 FY26Capital Markets

CARE Ratings Q1 FY26 earnings call: Revenue & Margins

Q1 FY26 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹94Cr
+19% YoY
−14.5% QoQ
Net profit
₹26Cr
+23.8% YoY
−39.5% QoQ
Margin
30%
+2 pp YoY
−13 pp QoQ

CARE Ratings Ltd Q1 FY26 key numbers

Revenue
Standalone EBITDA: Rs. 27.2 Crs, up 23% YoY, with 36% margin.

As stated in CARE Ratings Ltd's Q1 FY26 investor presentation · published 25 Sept 2026. Reported figures, not investment advice.

Based on CARE Ratings Ltd's Q1 FY26 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹1,617
Market cap₹5.0K Cr
P/E28.3

The short version

Standalone operating income for Q1 FY26: Rs. 75.6 Crs, up 16% YoY. Standalone Q1 FY26:.

From CARE Ratings Ltd's Q1 FY26 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Standalone operating income for Q1 FY26: Rs. 75.6 Crs, up 16% YoY
  • Standalone EBITDA: Rs. 27.2 Crs, up 23% YoY, with 36% margin
  • Standalone PAT: Rs. 29.1 Crs, up 21% YoY
  • Standalone EPS: Rs. 9.72
  • Consolidated operating income for Q1 FY26: Rs. 93.9 Crs, up 19% YoY
  • Consolidated EBITDA: Rs. 27.8 Crs, up 28% YoY, with 30% margin
  • Consolidated PAT: Rs. 26.5 Crs, up 24% YoY
  • Consolidated EPS: Rs. 8.61
  • Ratings business revenue: Rs. 82.9 Crs, up 18% YoY

2 more points from CARE Ratings Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

Standalone Q1 FY26:

Locked: what CARE Ratings Ltd said on margins

Also locked on this page: fundraising, order book

Free account, 30 seconds. No card needed.

Capital Expenditure Plans

It does provide macro-level insights on the Indian economy relevant to capex: - Government’s thrust on capex highlighted with Gross Fixed Capital Formation growth at 7.1% in FY25 (Page 11). - Centre’s capex-to-GDP budgeted at 3.1% in FY26, up from 1.7% during FY15-19 (Page 11). - Investment growth mainly driven by government capex focus; private capex revival remains uncertain (Page 3). The focus is on economic conditions supporting capex broadly, not on CARE Ratings’ direct capex activities.

Top-ranked in Capital Markets

Ranked on what management guided this quarter

Guidance-ranked
1BSE
Rev 2Mar 3
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The presentation notes a notable uptick in fundraising activity in the economy during Q1 FY26 compared to…

Locked: what CARE Ratings Ltd said on fundraising

Also locked on this page: margins, order book

Free account, 30 seconds. No card needed.

Order Book & Pipeline

See what CARE Ratings Ltd said on order book & pipeline — free account, 30 seconds.

CARE Ratings Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

CARE Ratings Ltd Q1 FY26 results — key figures

CARE Ratings Ltd Q1 FY26 reported results vs Q1 FY25, ₹ crore
₹ CrQ1 FY26Q1 FY25YoYQ4 FY25QoQ
Revenue9479+19%110-14.5%
Operating profit (EBITDA)2822+27.3%47-40.4%
Operating margin30%28%+2 pp43%-13 pp
Profit before tax3730+23.3%59-37.3%
Net profit (PAT)2621+23.8%43-39.5%
EPS (₹)8.616.94+24.1%14.24-39.5%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹164 Cr, net profit ₹72 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Capital Markets this season

  • ICRA (Q1 FY26)

    Revenue for Q1 FY2026 was INR 124.5 crore, up from INR 114.8 crore in Q1 FY2025, a growth of 8.4%. Key concall takeaways from ICRA Ltd's Q1 FY26 earnings call…

  • UTI AMC (Q1 FY26)

    Standalone Core Income (Sale of Services) Q1 FY26: ₹309 crore, up 13% YoY (Page 48) . Key concall takeaways from UTI Asset Management Company Ltd's Q1 FY26…

  • Geojit Financial Services (Q1 FY26)

    Total Income: ₹15,330 lakhs in Q1 FY26, down 14% YoY (₹17,748 lakhs in Q1 FY25) . Key concall takeaways from Geojit Financial Services Ltd's Q1 FY26 earnings…

  • Aditya AMC (Q1 FY26)

    Encouragement of SIPs contributing 45% to total AUM, promoting asset stickiness and stable inflows. Key concall takeaways from Aditya AMC's Q1 FY26 earnings…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

CARE Ratings Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were CARE Ratings Ltd Q1 FY26 results?

Standalone operating income for Q1 FY26: Rs. 75.6 Crs, up 16% YoY. Standalone Q1 FY26:.

What is CARE Ratings Ltd share price analysis?

CARE Ratings Ltd currently shows a neutral. The stock trades at a P/E of 28.3 with a market cap of ₹5,026 Cr. Investors should review the full earnings analysis for detailed insights.

Keep CARE Ratings Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.